EPIGENETIC SILENCING OF CYCLOOXYGENASE-2 AFFECTS CLINICAL OUTCOME IN GASTRIC CANCER
摘要
<p>The present invention discloses methods of using the methylation status of the COX-2 gene promoter region as a biomarker for a gastric cancer patient to determine a prognosis and a treatment regimen, and to monitor the progress of a treatment regimen.</p>
申请公布号
WO2008157437(A1)
申请公布日期
2008.12.24
申请号
WO2008US67027
申请日期
2008.06.13
申请人
JOHN WAYNE CANCER INSTITUTE;HOON, DAVE, S., B.;DE MAAT, MICHIEL
